Modern drug discovery demands an integrative approach, using many different technologies, but ultimately based on an understanding of the pathophysiology of the disease state to be treated. Targeting drugs at the main pathophysiological process is the key to success. This issue needs to be addressed with the multiple screening systems available, which can be used to find new leads.
No takes yet. Share an insight, caveat, or question.
Michael Spedding (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: